Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-05-24
2005-05-24
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S289000, C514S654000
Reexamination Certificate
active
06897241
ABSTRACT:
A method is presented for the preparation of topically applied compositions used for the treatment of regional pain, especially sympathetically mediated pain. NMDA receptor antagonists, such as ketamine or dextromethorphan, and one or more tricyclic antidepressants, such as amitriptyline, in combination, are employed.
REFERENCES:
patent: 2676177 (1954-04-01), Schnider
patent: 2928829 (1960-03-01), Mull
patent: 3006913 (1961-10-01), Mull
patent: 3055882 (1962-09-01), Mull
patent: 3205264 (1965-09-01), Tristram
patent: 3254124 (1966-03-01), Stevens
patent: 4777171 (1988-10-01), Beitner
patent: 5258386 (1993-11-01), Newman et al.
patent: 5260313 (1993-11-01), Frome
patent: 5366980 (1994-11-01), Smith
patent: 5446070 (1995-08-01), Mantelle
patent: 5817699 (1998-10-01), Flores et al.
patent: 4340767 (1995-06-01), None
patent: 0 431 663 (1990-11-01), None
patent: 2074026 (1981-10-01), None
patent: WO 9102527 (1991-03-01), None
patent: WO 9214453 (1992-09-01), None
patent: 9522965 (1995-08-01), None
patent: WO 9801157 (1998-01-01), None
Liu et al., Journal of Pharmacology and experimental therapeutics, (Oct., 1975) 195(1) 94-104 (abstract).*
Ebert et al., Neuroscience Letter, (1995) 187(3), pp. 165-168 (abstract).*
Embase Abstract, AN. 96229589, Lipman, A.G., “Analgesic drugs for neuropathic and sympathetically maintained pain”,Clinics in Geriatric Medicine,12:501-515 (1996).
Ortega-Alvaro, A. et al., “The Effects of Different Monoarminergic Antidepressants on the Analgesia Induced by Spinal Cord Adrenal medullary Transplants in the Formalin Test in Rats,”Anesthesia and Analgesia,84(4):816-820 (1997).
Sierralta, F. et al., “Effect of p-hlorophenylalanine and α-Methyltyrosine on the Antinociceptive Effect of Antidepressant Drugs,”Pharmacology and Toxicology,77(4):276-280 (1995).
Crowley, K.L. et al., “Clinical Application of Ketamine Ointment in the Treatment of Sympathetically Maintained Pain,”Pharmaceutical Compounding,2(2):122-127 (1998).
H. Willimann, P.Walde, P.L. Luisi et al., “Le cithin Organogel as Matrix for Transdermal Transport of Drugs”, Journal of Pharmaceutical Sciences, V.81,Nr.9 Sep. 1992.
Gordon L. Flynn, General Intro. Topical and Transdermal Drug Delivery Systems Topical Drug Bioavailability, Bioequivalence, and Penetration, Plenum Press, 1993, Chapter 20, pp. 369-391.
O. Shimoda; T. Kano; Takaki, et al., “Transdermal application of 10% lidocaine-gel for management of pain associated with herpes zoster”: Department of Anesthesiology, Kumamoto Rosai Hospital, Yatsushiro. Masui 1993 Aug.;42(B):1171-6, Abstract.
Foley & Lardner
Reiter Stephen E.
Spivack Phyllis G.
LandOfFree
Preparation of topical regional compositions for the relief... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparation of topical regional compositions for the relief..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparation of topical regional compositions for the relief... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3370162